Suppr超能文献

心脏移植患者晚期死亡的易患因素。

Predisposing factors for late mortality in heart transplant patients.

机构信息

Department of Cardiology I, University of Muenster, Germany.

Department of Cardiothoracic Surgery, University of Muenster, Germany.

出版信息

Cardiol J. 2021;28(5):746-757. doi: 10.5603/CJ.a2020.0011. Epub 2020 Feb 13.

Abstract

BACKGROUND

Because of the growing prevalence of terminal heart failure on the one hand and organ shortage on the other hand, an optimal care of heart transplant recipients based on the knowledge of potential risk factors not only early, but also in a long-term course after heart transplantation is of great importance. Therefore, the aim of the present study was to identify predisposing factors for late mortality in this patient collective.

METHODS

Data from long-term heart transplant patients collected during follow-up visits in the current center were retrospectively analyzed. Clinical, laboratory, including immune monitoring and apparative examination results were studied with regard to all-cause mortality.

RESULTS

One hundred and seventy-two patients after heart transplantation (mean: 13.2 ± 6.4 years) were divided into two groups: survivors (n = 133) and non-survivors (n = 39). In comparison with survivors, non-survivors were characterized by significantly more pronounced renal insufficiency with more frequent dialysis, anemia and worse functional status. Additionally, non-survivors obtained hearts from relevantly more obese donors. In a multivariate Cox regression analysis the following parameters were shown to be independent risk factors for increased mortality: CD4 percentage < 42%, C-reactive protein ≥ 0.5 mg/dL, presence of rejections requiring therapies in the past, onset of cardiac allograft vasculopathy < 5 years following heart transplantation and no use of beta-blockers.

CONCLUSIONS

Low CD4+ cell percentages, sustained inflammation, relevant organ rejections, early onset of transplant vasculopathy and no use of beta-blockers are risk factors for higher mortality in a long-term follow-up after heart transplantation.

摘要

背景

由于终末期心力衰竭的患病率不断上升,另一方面器官短缺,因此,基于潜在风险因素的知识,不仅在心脏移植早期,而且在心脏移植后长期,为心脏移植受者提供最佳护理非常重要。因此,本研究的目的是确定该患者群体中晚期死亡的易患因素。

方法

回顾性分析当前中心随访期间收集的长期心脏移植患者的数据。研究了与全因死亡率相关的临床、实验室(包括免疫监测和仪器检查结果)数据。

结果

172 名心脏移植后患者(平均:13.2 ± 6.4 年)分为两组:幸存者(n = 133)和非幸存者(n = 39)。与幸存者相比,非幸存者的肾功能明显更差,透析更频繁,贫血更严重,功能状态更差。此外,非幸存者接受的心脏来自明显更肥胖的供体。多变量 Cox 回归分析显示,以下参数是死亡率增加的独立危险因素:CD4 百分比<42%、C 反应蛋白≥0.5mg/dL、过去需要治疗的排斥反应、心脏移植物血管病发病<5 年以及未使用β受体阻滞剂。

结论

心脏移植后长期随访中,CD4+细胞百分比低、持续炎症、相关器官排斥反应、移植血管病早期发作和未使用β受体阻滞剂是死亡率较高的危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验